U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies

Cosmo Pharmaceuticals

Market Cap: CHF 1.0b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Sanofi

Market Cap: €96.7b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Sanofi

Market Cap: €96.7b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Hikma Pharmaceuticals

Market Cap: UK£3.6b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Regeneron Pharmaceuticals

Market Cap: US$59.8b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Hikma Pharmaceuticals

Market Cap: UK£3.6b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Merck

Market Cap: US$199.0b

Operates as a healthcare company worldwide.

Cosmo Pharmaceuticals

Market Cap: CHF 1.0b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Perrigo

Market Cap: US$2.9b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Teva Pharmaceutical Industries

Market Cap: US$22.1b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Evolus

Market Cap: US$735.7m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

Vetoquinol

Market Cap: €890.6m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

Novartis

Market Cap: CHF 189.4b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Viatris

Market Cap: US$11.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Pharming Group

Market Cap: €877.0m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Iovance Biotherapeutics

Market Cap: US$767.1m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Johnson & Johnson

Market Cap: US$425.5b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Sarepta Therapeutics

Market Cap: US$1.8b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Halozyme Therapeutics

Market Cap: US$8.8b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Novartis

Market Cap: CHF 189.4b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

ACADIA Pharmaceuticals

Market Cap: US$2.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Haleon

Market Cap: UK£29.5b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Beximco Pharmaceuticals

Market Cap: UK£52.5b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

HUTCHMED (China)

Market Cap: UK£2.0b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Oxford Biomedica

Market Cap: UK£699.5m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Pfizer

Market Cap: US$137.0b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Novo Nordisk

Market Cap: DKK 1.7t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Geron

Market Cap: US$848.6m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Vertex Pharmaceuticals

Market Cap: US$96.6b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Bayer

Market Cap: €27.1b

Operates as a life science company worldwide.

Amicus Therapeutics

Market Cap: US$2.6b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

Johnson & Johnson

Market Cap: €425.3b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

hVIVO

Market Cap: UK£54.8m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

CureVac

Market Cap: US$1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Merck KGaA

Market Cap: €47.0b

Operates as a science and technology company in Germany.

Emergent BioSolutions

Market Cap: US$436.4m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.